Addressing insurance‐related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery
Sign Up to like & getrecommendations! Published in 2022 at "Obesity"
DOI: 10.1002/oby.23556
Abstract: The past decade has witnessed significant progress in the development of new antiobesity medications, with several having greater efficacy than pharmacological agents previously approved by the Food and Drug Administration (FDA). Despite the potential of… read more here.
Keywords: antiobesity medications; coverage; insurance; antiobesity ... See more keywords